Otto Warburg's contributions to current concepts of cancer metabolism
暂无分享,去创建一个
Chi V. Dang | C. Dang | W. Koppenol | P. Bounds | Willem H. Koppenol | Patricia L. Bounds | P. L. Bounds
[1] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[2] Bin Wang,et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.
[3] J. Licht,et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.
[4] A. Levine,et al. The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.
[5] Eileen White,et al. Autophagy and Metabolism , 2010, Science.
[6] Elizabeth L. Johnson,et al. Quiescent Fibroblasts Exhibit High Metabolic Activity , 2010, PLoS biology.
[7] C. Dang,et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.
[8] Hai Yan,et al. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. , 2010, Journal of the National Cancer Institute.
[9] P. Devilee,et al. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? , 2010, Current opinion in genetics & development.
[10] J. Mackey,et al. Metabolic Modulation of Glioblastoma with Dichloroacetate , 2010, Science Translational Medicine.
[11] Yibin Wang,et al. Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. , 2010, The Journal of clinical investigation.
[12] W. Wheaton,et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.
[13] K. Vousden. Alternative fuel—another role for p53 in the regulation of metabolism , 2010, Proceedings of the National Academy of Sciences.
[14] A. Levine,et al. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function , 2010, Proceedings of the National Academy of Sciences.
[15] K. Vousden,et al. The role of p53 in glucose metabolism. , 2010, Current opinion in cell biology.
[16] E. Gottlieb,et al. Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.
[17] S. Sugano,et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species , 2010, Proceedings of the National Academy of Sciences.
[18] C. Tinelli,et al. Glutamine Synthetase Immunostaining Correlates with Pathologic Features of Hepatocellular Carcinoma and Better Survival after Radiofrequency Thermal Ablation , 2010, Clinical Cancer Research.
[19] D. Dressman,et al. Heteroplasmic mitochondrial DNA mutations in normal and tumor cells , 2010, Nature.
[20] Tak W. Mak,et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations , 2010, The Journal of experimental medicine.
[21] Chi V Dang,et al. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.
[22] G. Semenza. HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.
[23] Jeffrey W. Smith,et al. Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation , 2010, Molecular and Cellular Biology.
[24] R. Deberardinis,et al. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.
[25] M. Assanah,et al. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.
[26] G. Semenza,et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression , 2010, Proceedings of the National Academy of Sciences.
[27] W. Zong,et al. Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition* , 2009, The Journal of Biological Chemistry.
[28] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[29] James R Broach,et al. Protein kinase A and TORC1 activate genes for ribosomal biogenesis by inactivating repressors encoded by Dot6 and its homolog Tod6 , 2009, Proceedings of the National Academy of Sciences.
[30] Kevin M. Ryan,et al. p53 and metabolism , 2009, Nature Reviews Cancer.
[31] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[32] Steven P. Gygi,et al. SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma , 2009, Science.
[33] Hanna Y. Irie,et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.
[34] O. Sansom,et al. Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism. , 2009, Gastroenterology.
[35] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[36] S. Naylor,et al. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. , 2009, Human molecular genetics.
[37] Kun-Liang Guan,et al. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.
[38] N. Hay,et al. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.
[39] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[40] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[41] A. Lane,et al. Targeting aspartate aminotransferase in breast cancer , 2008, Breast Cancer Research.
[42] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[43] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[44] Renu M. Stephen,et al. Regulation of the Warburg effect in early-passage breast cancer cells. , 2008, Neoplasia.
[45] Guido Kroemer,et al. Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.
[46] W. Kaelin,et al. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.
[47] J. Hayashi,et al. ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.
[48] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[49] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[50] G. Semenza,et al. Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.
[51] Nicola Zamboni,et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.
[52] A. Maitra,et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck , 2007, Proceedings of the National Academy of Sciences.
[53] S. Henderson,et al. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production , 2007, Proceedings of the National Academy of Sciences.
[54] P. Pedersen. The cancer cell’s “power plants” as promising therapeutic targets: An overview , 2007, Journal of bioenergetics and biomembranes.
[55] R. Braun,et al. Modeling of oxygen transport across tumor multicellular layers. , 2007, Microvascular research.
[56] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[57] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[58] Oksana Gavrilova,et al. p53 Regulates Mitochondrial Respiration , 2006, Science.
[59] C. Boschek,et al. Pyruvate kinase type M2 and its role in tumor growth and spreading. , 2005, Seminars in cancer biology.
[60] S. Schreiber,et al. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[61] John A. Hall,et al. mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[62] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[63] C. Thompson,et al. Akt and Hypoxia-Inducible Factor-1 Independently Enhance Tumor Growth and Angiogenesis , 2004, Cancer Research.
[64] C. Thompson,et al. Phosphatidylinositol 3-Kinase/Akt Signaling Is Neither Required for Hypoxic Stabilization of HIF-1α nor Sufficient for HIF-1-dependent Target Gene Transcription* , 2002, The Journal of Biological Chemistry.
[65] G. Semenza,et al. HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.
[66] P. Thibault,et al. Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.
[67] C. Dang,et al. Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.
[68] A. Koong,et al. Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.
[69] K. Chien,et al. p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[70] J. Nevins,et al. Ras enhances Myc protein stability. , 1999, Molecular cell.
[71] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[72] T. Fojo,et al. p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription* , 1998, The Journal of Biological Chemistry.
[73] C. Dang,et al. A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] G. Semenza,et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. , 1997, Cancer research.
[75] G. Semenza,et al. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. , 1997, Cancer research.
[76] D. Vertommen,et al. Phosphorylation and Activation of Heart 6-Phosphofructo-2-kinase by Protein Kinase B and Other Protein Kinases of the Insulin Signaling Cascades* , 1997, The Journal of Biological Chemistry.
[77] R A Jungmann,et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[78] J. Gleadle,et al. Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. , 1997, Blood.
[79] M. Guppy,et al. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. , 1994, The Journal of biological chemistry.
[80] G. Semenza,et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.
[81] B. Ebert,et al. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[82] I. Goto,et al. Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma. , 1992, Cancer research.
[83] H. Lodish,et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.
[84] B. Crabtree,et al. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. , 1985, Quarterly journal of experimental physiology.
[85] K. Brand. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. , 1985, The Biochemical journal.
[86] Jonathan A. Cooper,et al. Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro. , 1984, The Journal of biological chemistry.
[87] A. Lehninger,et al. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. , 1984, The Journal of biological chemistry.
[88] J P Freyer,et al. In situ oxygen consumption rates of cells in V‐79 multicellular spheroids during growth , 1984, Journal of cellular physiology.
[89] Robert A. Weinberg,et al. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.
[90] H A Krebs,et al. Otto Heinrich Warburg, 1883-1970 , 1972, Biographical Memoirs of Fellows of the Royal Society.
[91] H. Morris,et al. Glutaminase activities and growth rates of rat hepatomas. , 1969, Cancer research.
[92] Susan Goldhor,et al. The History of Cell Respiration and Cytochrome , 1966, The Yale Journal of Biology and Medicine.
[93] J. Turner,et al. OXYGEN AS A FACTOR IN PHOTOSYNTHESIS , 1962, Biological reviews of the Cambridge Philosophical Society.
[94] B. Hess,et al. Spectroscopic Evidence of Metabolic Control , 1959, Science.
[95] O. Warburg. On respiratory impairment in cancer cells. , 1956, Science.
[96] B. Chance,et al. Some Patterns of the Respiratory Pigments of Ascites Tumors of Mice. , 1952, Science.
[97] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.
[98] Franz Wind,et al. Über den Stoffwechsel von Tumoren im Körper , 1926, Klinische Wochenschrift.
[99] C. Cori,et al. THE CARBOHYDRATE METABOLISM OF TUMORS II. CHANGES IN THE SUGAR, LACTIC ACID, AND CO2-COMBINING POWER OF BLOOD PASSING THROUGH A TUMOR , 1925 .
[100] C. Cori,et al. THE CARBOHYDRATE METABOLISM OF TUMORS I. THE FREE SUGAR, LACTIC ACID, AND GLYCOGEN CONTENT OF MALIGNANT TUMORS , 1925 .
[101] O. Warburg. über den Stoffwechsel der Carcinomzelle , 1925, Klinische Wochenschrift.
[102] O. Warburg,et al. Versuche an Überlebendem Carcinomgewebe , 1923, Klinische Wochenschrift.
[103] A. Einstein. Emil Warburg als Forscher , 1922, Naturwissenschaften.
[104] A Krogh,et al. The rate of diffusion of gases through animal tissues, with some remarks on the coefficient of invasion , 1919, The Journal of physiology.
[105] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[106] K. Flaherty,et al. HIF- α effects on c-Myc distinguish two subtypes of sporadic VHL -deficient clear cell renal carcinoma , 2009 .
[107] M. Pino,et al. Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1 α and -2 α in Colon Cancer , 2009 .
[108] P. Mahadevan,et al. An overview , 2007, Journal of Biosciences.
[109] O. Warburg. Notizen zur Entwicklungsphysiologie des Seeigeleies , 2005, Pflüger's Archiv für die gesamte Physiologie des Menschen und der Tiere.
[110] H. Varmus,et al. Oncogenes come of age. , 2005, Cold Spring Harbor symposia on quantitative biology.
[111] O. Warburg. Über den heutigen Stand des Carcinomproblems , 2005, Naturwissenschaften.
[112] Jan Kitajewski,et al. New targets of β-catenin signaling in the liver are involved in the glutamine metabolism , 2002, Oncogene.
[113] S. Sri Kantha. The question of nepotism in the award of Nobel prizes: a critique of the view of Hans Krebs. , 1991, Medical hypotheses.
[114] S. Kantha. The question of nepotism in the award of Nobel prizes: a critique of the view of Hans Krebs. , 1991 .
[115] D. Nachmansohn. German-Jewish pioneers in science, 1900-1933 , 1979 .
[116] H. Krebs,et al. Otto Warburg : Zellphysiologe, Biochemiker, Mediziner : 1883-1970 , 1979 .
[117] E. Racker. Bioenergetics and the problem of tumor growth. , 1972, American scientist.
[118] S. Weinhouse. On respiratory impairment in cancer cells. , 1956, Science.
[119] H G Crabtree,et al. Observations on the carbohydrate metabolism of tumours. , 1929, The Biochemical journal.
[120] O. Warburg,et al. Über den Stoffwechsel der Tumoren : Arbeiten aus dem Kaiser Wilhelm Institut für Biologie, Berlin- Dahlem , 1926 .